Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 907 of 1,261
  1. US 8263122

    Wet granulation using a water sequestering agent

    Rigel Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  2. US 8263091

    Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  3. US 8263588

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  4. US 8263605

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  5. US 8263095

    Methods of use for peptides having activities of insulin like growth factor-1

    CAREGEN CO., LTD. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  6. US 8263085

    Gammaretrovirus associated with cancer

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  7. US 8263677

    Removable color gel basecoat for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  8. US 8263062

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  9. US 8263657

    Inhibitors against the production and release of inflammatory cytokines

    Institute of Medicinal Molecular Design, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  10. US 8263632

    Aminopyridine derivatives having Aurora A selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  11. US 8263549

    C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  12. FR 2972192

    COMPOSITION PHARMACEUTIQUE DESTINEE A LA PREVENTION OU AU TRAITEMENT DES CANCERS

    BIOCODEX [FR] · Granted Sep 7, 2012 · Expires Sep 2, 2032

    granted
  13. US 8258252

    Sustained-release composition and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  14. US 8257699

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  15. US 8257915

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  16. US 8258263

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  17. US 8257932

    Interfacing nanostructures to biological cells

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  18. US 8258274

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  19. US 8257918

    Intelligent nanomedicine integrating diagnosis and therapy

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  20. US 8257719

    Oral care layer and related method of manufacture

    Ranir, LLC · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  21. US 8258257

    Claudin-4 binding peptides, compositions and methods of use

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  22. US 8258163

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  23. US 8258148

    Spiroindoline modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  24. US 8258142

    Substituted 8-[6-amino-3-pyridyl]xanthines

    Dogwood Pharmaceuticals, Inc. · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.